Skip to main content
. 2023 Dec 14;16:249–276. doi: 10.2147/CEG.S360248

Table 4.

Biologic Therapy for Management of EIMs

EIM Biologic Therapy Class
Peripheral arthritis TNF inhibitors, IL 12/23, upadacitinib, vedolizumab?
Spondyloarthropathy TNF inhibitors, upadacitinib
Dermatologic manifestations TNF inhibitors, IL12/23?, upadacitinib?
Ocular manifestations TNF inhibitors

Notes: ?: This symbol next to medications indicates there is mixed or inconclusive evidence supporting their use for the specific EIM.